Cargando…
Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
Genome-wide association study (GWAS) has determined the metabotropic glutamate receptor 7 (GRM7) gene as potential locus for schizophrenia risk variants; However, the relationship between the GRM7 variants and the risk of schizophrenia is still uncertain, and there are significant individual variati...
Autores principales: | Liang, Wei, Yu, Hao, Su, Yi, Lu, Tianlan, Yan, Hao, Yue, Weihua, Zhang, Dai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054263/ https://www.ncbi.nlm.nih.gov/pubmed/32127521 http://dx.doi.org/10.1038/s41398-020-0763-4 |
Ejemplares similares
-
Association of MTHFR C677T Polymorphism With Antipsychotic-Induced Change of Weight and Metabolism Index
por: Su, Yi, et al.
Publicado: (2021) -
Deleterious GRM1 Mutations in Schizophrenia
por: Ayoub, Mohammed Akli, et al.
Publicado: (2012) -
Correlation between variants of the CREB1 and GRM7 genes and risk of depression
por: Wang, Li, et al.
Publicado: (2023) -
Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy
por: Marafi, Dana, et al.
Publicado: (2020) -
ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study
por: Lu, Zhe, et al.
Publicado: (2022)